Swarnali Kundu received her M.Sc. in Biotechnology from the Indian Institute of Technology Bombay (IIT-B), Mumbai, India, and is now pursuing a Ph.D. in Neuroscience with the TANDEM graduate school at the Universitätsklinikum des Saarlandes Homburg (Saar) and the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS). Previously, she has worked as a Research associate at the Max Planck Institute for Heart and Lung Research (MPI-HLR) in Bad Nauheim, Hessen. Her research topics mainly include: KRT3, KRT12, PAX6, PAX6(5a), FOXC1, inflammation, cytokines, cornea, retina, vesicle cycling at the retinal synapse, ribbon synapses.